No Data
Cathie Wood's ARK Investment Buys 96.2K Shares of Intellia Therapeutics Today
Will Intellia Therapeutics (NASDAQ:NTLA) Spend Its Cash Wisely?
Why Intellia Therapeutics (NTLA) Is the Worst ARK Stock to Buy According to Short Sellers
Lilly Tops Morgan Stanley's Biopharma Pick List for 2025
Express News | Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)